Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2002;16(5):303-15.
doi: 10.2165/00023210-200216050-00003.

CNS manifestations of cytomegalovirus infections: diagnosis and treatment

Affiliations
Review

CNS manifestations of cytomegalovirus infections: diagnosis and treatment

Matthias Maschke et al. CNS Drugs. 2002.

Abstract

Cytomegalovirus (CMV) infection of the CNS occurs most commonly in patients with severe immunosuppression such as those with advanced HIV infection (i.e. AIDS) or those who have undergone bone marrow or solid organ transplantation. Immunocompetent patients are affected very rarely. The infection of the CNS may affect the brain (diffuse encephalitis, ventriculoencephalitis, cerebral mass lesions) or the spinal cord (transverse myelitis, polyradiculomyelitis). Diagnosis is very difficult and should be based on clinical presentation, results of imaging and virological markers. The most specific diagnostic tool is the detection of CMV DNA by polymerase chain reaction in the CSF. Treatment should be initiated promptly if CMV infection is suspected. Antiviral therapy consists of intravenous ganciclovir, intravenous foscarnet or a combination of both. Cidofovir is the treatment of second choice. Patients who experience clinical improvement or stabilisation during induction therapy should be given maintenance therapy. After immune reconstitution (in HIV-positive patients) or discontinuation of immunosuppressive therapy (in transplant recipients), maintenance therapy may be stopped. Despite therapy, the prognosis for long-term survival is very poor, especially in patients with AIDS.

PubMed Disclaimer

References

    1. Antimicrob Agents Chemother. 1993 May;37(5):1010-4 - PubMed
    1. J Clin Virol. 2001 Jun;21(3):223-8 - PubMed
    1. Clin Pharmacol Ther. 1986 Sep;40(3):281-6 - PubMed
    1. Mol Diagn. 1999 Mar;4(1):37-43 - PubMed
    1. J Comput Assist Tomogr. 1994 Jan-Feb;18(1):7-11 - PubMed

MeSH terms